Sheridan, W P <br/><br/>
Mechanism of action and clinical trials of Mpl ligand.  [electronic resource] 

 -  Current opinion in hematology  Sep 1997 
 - 312-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1065-6251 
<br/><br/><label>Standard No.: </label>10.1097/00062752-199704050-00003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials, Phase I as Topic<br/>Gene Expression<br/>Hematopoiesis<br/>Humans<br/>Megakaryocytes--cytology<br/>Models, Biological<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols<br/>Thrombopoietin--administration & dosage